(Q38967744)

8 September 2017

title

Chitosan-assisted immunotherapy for intervention of experimental leishmaniasis via amphotericin B-loaded solid lipid nanoparticles (English)

1 reference

8 September 2017

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25106894%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Vineet Jain

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25106894%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Annie Gupta

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25106894%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Vivek K Pawar

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25106894%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Shalini Asthana

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25106894%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Anuradha Dube

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25106894%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Manish K Chourasia

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25106894%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

publication date

9 August 2014

1 reference

Applied Biochemistry and Biotechnology

8 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25106894%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

174

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25106894%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25106894%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

1309-1330

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25106894%20AND%20SRC:MED&resulttype=core&format=json

Mucosal leishmaniasis: an underestimated presentation of a neglected disease

2 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Advances in leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Leishmania-macrophage interactions: insights into the redox biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Amphotericin B and its new derivatives - mode of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Antifungal agents: mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

How do sterols determine the antifungal activity of amphotericin B? Free energy of binding between the drug and its membrane targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Amphotericin B: current understanding of mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Strategies for the design of orally bioavailable antileishmanial treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

AmbiOnp: solid lipid nanoparticles of amphotericin B for oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Solid lipid nanoparticles bearing flurbiprofen for transdermal delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Induction of Th1-type immune response by chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen Der p 2 for oral vaccination in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Immunoadjuvant chemotherapy of visceral leishmaniasis in hamsters using amphotericin B-encapsulated nanoemulsion template-based chitosan nanocapsules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Chitosan-based macrophage-mediated drug targeting for the treatment of experimental visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Methods for the preparation and manufacture of polymeric nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Microencapsulation of hemoglobin in chitosan-coated alginate microspheres prepared by emulsification/internal gelation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

The effects of cryoprotectants on the freeze-drying of ibuprofen-loaded solid lipid microparticles (SLM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Nanosized ethosomes bearing ketoprofen for improved transdermal delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Amphotericin B-gum arabic conjugates: synthesis, toxicity, bioavailability, and activities against Leishmania and fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Design and development of Amphotericin B bearing polycaprolactone microparticles for macrophage targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Generation of avirulent Leishmania parasites and induction of nitric oxide production in macrophages by using polyacrylic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Targeted drug delivery to macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Involvement of oxidative damage in erythrocyte lysis induced by amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Modification of gold nanorods using phosphatidylcholine to reduce cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Mechanism of macrophage activation by chitin derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Down-regulation of mannose receptors on macrophages after infection with Leishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Comparative internalization and recycling of different amphotericin B formulations by a macrophage-like cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Activation of the MAPK, ERK, following Leishmania amazonensis infection of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

The effect of water-soluble chitosan on macrophage activation and the attenuation of mite allergen-induced airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Effects of the aggregation state of amphotericin B on its toxicity to mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

Interactions of amphotericin B derivatives with lipid membranes—A molecular dynamics study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1084-Y

10.1007/S12010-014-1084-Y

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25106894%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

2 June 2020

1003535477

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25106894%20AND%20SRC:MED&resulttype=core&format=json